New York State Teachers Retirement System (NYSTRS)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.62M Sell
20,950
-3,559
-15% -$839K 0.01% 699
2026
Q1
$4.89M Sell
24,509
-2,441
-9% -$483K 0.01% 785
2025
Q4
$5.09M Hold
26,950
0.01% 805
2025
Q3
$4.77M Hold
26,950
0.01% 831
2025
Q2
$3.06M Sell
26,950
-100
-0.4% -$10.7K 0.01% 939
2025
Q1
$2.84M Hold
27,050
0.01% 953
2024
Q4
$2.9M Hold
27,050
0.01% 984
2024
Q3
$2.71M Hold
27,050
0.01% 1020
2024
Q2
$2.28M Sell
27,050
-200
-0.7% -$15.9K ﹤0.01% 1067
2024
Q1
$1.99M Hold
27,250
﹤0.01% 1124
2023
Q4
$1.95M Sell
27,250
-100
-0.4% -$5.9K ﹤0.01% 1124
2023
Q3
$1.64M Sell
27,350
-200
-0.7% -$13.2K ﹤0.01% 1145
2023
Q2
$1.99M Sell
27,550
-100
-0.4% -$7.5K ﹤0.01% 1092
2023
Q1
$2.03M Sell
27,650
-400
-1% -$28.4K ﹤0.01% 1076
2022
Q4
$1.87M Sell
28,050
-16,914
-38% -$1.1M ﹤0.01% 1106
2022
Q3
$2.42M Buy
44,964
+160
+0.4% +$9.41K 0.01% 990
2022
Q2
$2.49M Buy
44,804
+160
+0.4% +$9.08K 0.01% 997
2022
Q1
$3.13M Hold
44,644
0.01% 993
2021
Q4
$4.3M Buy
44,644
+321
+0.7% +$29.7K 0.01% 899
2021
Q3
$3.85M Buy
44,323
+7,935
+22% +$614K 0.01% 927
2021
Q2
$2.98M Hold
36,388
0.01% 1021
2021
Q1
$3.46M Sell
36,388
-8,336
-19% -$788K 0.01% 966
2020
Q4
$2.77M Sell
44,724
-160
-0.4% -$9.12K 0.01% 1008
2020
Q3
$2.67M Hold
44,884
0.01% 934
2020
Q2
$3.13M Hold
44,884
0.01% 875
2020
Q1
$2.04M Hold
44,884
0.01% 944
2019
Q4
$2.92M Buy
44,884
+160
+0.4% +$10.7K 0.01% 978
2019
Q3
$2.78M Hold
44,724
0.01% 973
2019
Q2
$3.19M Hold
44,724
0.01% 942
2019
Q1
$3.51M Sell
44,724
-1,763
-4% -$134K 0.01% 910
2018
Q4
$3.94M Sell
46,487
-14,429
-24% -$1.54M 0.01% 827
2018
Q3
$10.4M Buy
60,916
+1,764
+3% +$266K 0.02% 542
2018
Q2
$7.64M Buy
59,152
+235
+0.4% +$26.2K 0.02% 641
2018
Q1
$6.07M Sell
58,917
-2,404
-4% -$238K 0.01% 737
2017
Q4
$5.24M Buy
61,321
+835
+1% +$72.4K 0.01% 817
2017
Q3
$5.14M Buy
60,486
+802
+1% +$63.5K 0.01% 807
2017
Q2
$4.52M Sell
59,684
-2,886
-5% -$202K 0.01% 855
2017
Q1
$4.13M Sell
62,570
-1,443
-2% -$94.9K 0.01% 912
2016
Q4
$4.06M Sell
64,013
-3,045
-5% -$192K 0.01% 931
2016
Q3
$4.27M Sell
67,058
-481
-0.7% -$35.3K 0.01% 866
2016
Q2
$5.03M Buy
67,539
+5,129
+8% +$381K 0.01% 781
2016
Q1
$4.17M Hold
62,410
0.01% 859
2015
Q4
$4.22M Buy
62,410
+10,768
+21% +$665K 0.01% 842
2015
Q3
$2.76M Buy
51,642
+6,870
+15% +$417K 0.01% 1032
2015
Q2
$2.82M Buy
44,772
+161
+0.4% +$8.78K 0.01% 1076
2015
Q1
$2.15M Buy
44,611
+3,595
+9% +$138K 0.01% 1165
2014
Q4
$1.36M Buy
41,016
+24,685
+151% +$803K ﹤0.01% 1277
2014
Q3
$479K Buy
16,331
+801
+5% +$26.6K ﹤0.01% 1403
2014
Q2
$603K Hold
15,530
﹤0.01% 1390
2014
Q1
$652K Buy
15,530
+962
+7% +$40.1K ﹤0.01% 1390
2013
Q4
$478K Buy
+14,568
New +$475K ﹤0.01% 1433

Other funds holding LGND

New York State Teachers Retirement System (NYSTRS)'s LGND Position: Q2 2026 in Review

New York State Teachers Retirement System (NYSTRS) reduced its Ligand Pharmaceuticals (LGND) stake by 15% in Q2 2026, selling an estimated $839K and leaving 20,950 shares worth $6.62M. The position accounts for 0.01% of the portfolio, ranked #699.

New York State Teachers Retirement System (NYSTRS) first reported a position in LGND in Q4 2013 and has held it in 51 quarters since. The position peaked at $10.4M in Q3 2018. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • New York State Teachers Retirement System (NYSTRS) held 20,950 shares of Ligand Pharmaceuticals worth $6.62M as of Q2 2026.
  • New York State Teachers Retirement System (NYSTRS) sold 3,559 Ligand Pharmaceuticals shares in Q2 2026, an estimated $839K.
  • Ligand Pharmaceuticals made up 0.01% of New York State Teachers Retirement System (NYSTRS)'s portfolio in Q2 2026, its #699 holding.
  • New York State Teachers Retirement System (NYSTRS) first reported a position in Ligand Pharmaceuticals in Q4 2013 and has held it in 51 quarters since.
  • New York State Teachers Retirement System (NYSTRS)'s Ligand Pharmaceuticals position peaked at $10.4M in Q3 2018.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q2 2026, filed 23 Jul 2026.